Marinus Pharmaceuticals(MRNS) - 2024 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 15, 2024 Marinus Pharmaceuticals, Inc. (Exact name of registrant as specified in its charter) Delaware 001-36576 20-0198082 (State or other jurisdiction of (Commission File Number) (IRS Employer Identification incorporation) No.) 5 Radnor Corporate Center, Suite 500 19087 100 Matsonford R ...